This is relevant because only genes with evidence of Moderate or above should be included in clinical diagnostic testing.21 For SLC31A1, we determined a Moderate level of evidence, confirming its association with autosomal recessive SLC31A1-related neurodevelopmental disorder. Here, SLC31A1 is linked to neurodevelopmental disorder.